Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.39 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 3/20 | 0.39 |
| ▸ | BACE1 | P56817 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 4/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21344240 | 0.87 | ALDH1A1 (0.42) | ALDH1A1CYP1A2MEN1KMT2AHPGD | |
| SCHEMBL22992172 | 0.87 | PDE4B (0.43) | ALDH1A1MEN1KMT2APDE4BPOLB | |
| SCHEMBL22954945 | 0.86 | MEN1 (0.44) | ALDH1A1CYP1A2MEN1KMT2APDE4B | |
| SCHEMBL24120301 | 0.85 | ALDH1A1 (0.39) | ALDH1A1CYP1A2MEN1KMT2APDE4B | |
| SCHEMBL17302877 | 0.81 | USP2 (0.32) | ALDH1A1LMNAPOLB | |
| SCHEMBL22992066 | 0.80 | GRM4 (0.39) | PDE4BGAAKDM4EMAPT | |
| SCHEMBL21344670 | 0.79 | CHRM2 (0.42) | ALDH1A1CYP1A2MEN1KMT2AACHE | |
| SCHEMBL29342611 | 0.78 | HTT (0.43) | ALDH1A1MEN1KMT2ALMNAHPGD | |
| SCHEMBL22908538 | 0.77 | CCR8 (0.41) | ALDH1A1CYP1A2MEN1KMT2ALMNA | |
| SCHEMBL22955951 | 0.77 | ACHE (0.43) | ALDH1A1MEN1KMT2AACHEBACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12043599-B2 | Herbicidal compounds | SYNGENTA PARTICIPATIONS AG (CH) | 2024-07-23 | — | — | US | disclosed |
| US-20210047274-A1 | HERBICIDAL COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2021-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210047274-A1 | HERBICIDAL COMPOUNDS | DDT, CBR3, GLRX3 | ALDH1A1 57/4885CYP1A2 14/4885MEN1 3738/4885 |
| US-12043599-B2 | Herbicidal compounds | DDT, CBR3, GLRX3 | ALDH1A1 57/4885CYP1A2 14/4885MEN1 3738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.